CSIMarket
 
Mira Pharmaceuticals Inc   (NASDAQ: MIRA)
Other Ticker:  
 
 
Price: $1.1500 $-0.02 -1.709%
Day's High: $1.22 Week Perf: -0.86 %
Day's Low: $ 1.14 30 Day Perf: -22.82 %
Volume (M): 584 52 Wk High: $ 4.12
Volume (M$): $ 672 52 Wk Avg: $1.21
Open: $1.19 52 Wk Low: $0.51



 Market Capitalization (Millions $) 17
 Shares Outstanding (Millions) 15
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Mira Pharmaceuticals Inc
Mira Pharmaceuticals Inc is a pharmaceutical company that specializes in the research, development, and production of innovative medicines. The company aims to improve global health by focusing on areas of unmet medical needs and diseases with limited treatment options. Mira Pharmaceuticals Inc is known for its cutting-edge scientific expertise, state-of-the-art facilities, and commitment to delivering high-quality and effective medications. The company works closely with healthcare professionals, regulatory authorities, and global partners to ensure that its products meet the highest standards of safety and efficacy. Overall, Mira Pharmaceuticals Inc is dedicated to making a positive impact on patients' lives and contributing to the advancement of healthcare worldwide.


   Company Address: 1200 Brickell Avenue Miami 33131 FL
   Company Phone Number: 289-0835   Stock Exchange / Ticker: NASDAQ MIRA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BGNE        1.21% 
BMY   -7.48%    
REGN        6.47% 
TEVA   -3%    
VRTX   -3%    
VTRS   -2.08%    
• View Complete Report
   



Iterum Therapeutics Plc

The Major Pharmaceutical Preparations company added positive story for the investors, presenting a relevant improvement in financial interval ending December 31 2024 with operating shortfall of $-3.67 million

The shareholders haven't anticipated some changes at the top-line during the the October to December 31 2024 reporting cycle at the ITRM. However, they monitor the company's operating shortfall which was at $-3.67 million, during the matching time.

Scpharmaceuticals Inc

Scpharmaceuticals Inc has failed to turn into profitability despite the epic Surge in revenue in the most recent fiscal period

Scpharmaceuticals Inc announced very strong Revenue elevation of 164.12 % year on year to $10.03 million in the third quarter of 2024, but increased a deficit per share at $-0.75. Major Pharmaceutical Preparations company's business advanced at higher rate in contrast to the the revenue at almost all of the Major Pharmaceutical Preparations sector peers, in the third quarter of 2024 the two third entities in Major Pharmaceutical Preparations sectors saw the business elevation of 9.75% relative to the similar period a year ago.

Eledon Pharmaceuticals Inc

Major Pharmaceutical Preparations company, contraction in the operating results during the financial third quarter of 2024

The Major Pharmaceutical Preparations industry experts start to analyze the third quarter of 2024 performance. Today those experts observe operating shortfall of $-20.51 million, from the company, which has not specified any revenue so far, for the respective July to September 30 2024 quarter.

Terns Pharmaceuticals Inc

In thethird quarter of 2024 earnings season operating deficit showed enhancement to $-33.184 million, at the Terns Pharmaceuticals Inc

After the leaders in the Major Pharmaceutical Preparations industry, a few overlooked corporations are publishing their numbers. TERN mentioned it has clinched operating deficit of $-24.939 million, for the third quarter of 2024.

Synlogic Inc

A shortfall of $-0.01 per Share at the company in July to September 30 2024 span

For the July to September 30 2024 span Synlogic Inc lost money of $-0.01 per share compare to $-2.57 a year prior and Income per Share fell from $0.16 per share from the prior quarter. The revenue remained unscathed to $0.00 million from $0.39 million in the corresponding quarter a year prior and sequentially from $0.00 million.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com